Kangmei Pharma | 600518 - Current Assets


Kangmei Pharma reported CNY6.8B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Avita Medical AUD 35.49M 760K Dec/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Genomma Lab Internacional MXN 13.66B 822.6M Mar/2026
Hypermarcas BRL 6.71B 663.99M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Jiangsu Hengrui CNY 52.04B 553.82M Mar/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Moderna USD 5.77B 774M Mar/2026
Organon & Co USD 4.93B 580M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Sh Fosun Pharma CNY 33.96B 144.01M Mar/2026
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Viatris USD 10.92B 1.13B Mar/2026
Wuxi Apptec CNY 65.17B 3.49B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026